Acurx Pharmaceuticals, Inc. short interest in 2021
In 2021, Acurx Pharmaceuticals, Inc.'s disclosed short interest ran from 1.19% of shares outstanding on 13 Aug 2021 to 1.60% on 31 Dec 2021, a change of +0.41 percentage points. The year's high was 1.70% on 15 Dec 2021 and its low 0.76% on 31 Aug 2021, averaging 1.19% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.80 days on 15 Dec 2021. Full history: Acurx Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 1.19% (13 Aug 2021)
- End of year
- 1.60% (31 Dec 2021)
- Change
- +0.41 pp
- High
- 1.70% (15 Dec 2021)
- Low
- 0.76% (31 Aug 2021)
- Average
- 1.19%
- Highest days to cover
- 4.80 (15 Dec 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Aug 2021 | 1.19% | 1.07 | 10-Q filed |
| 31 Aug 2021 | 0.76% | 1.00 | results (8-K) |
| 15 Sep 2021 | 0.95% | 1.41 | |
| 30 Sep 2021 | 1.06% | 1.60 | |
| 15 Oct 2021 | 1.01% | 1.09 | |
| 29 Oct 2021 | 1.18% | 2.20 | |
| 15 Nov 2021 | 1.35% | 2.44 | 10-Q filed |
| 30 Nov 2021 | 1.12% | 2.79 | results (8-K) |
| 15 Dec 2021 | 1.70% | 4.80 | |
| 31 Dec 2021 | 1.60% | 4.40 |
See also: Acurx Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.